Author/Authors :
Hirohisa Nakamae، نويسنده , , Kei Tsumura، نويسنده , , Masayuki Hino، نويسنده , , Tomoshige Hayashi، نويسنده , , Noriyuki Tatsumi، نويسنده ,
Abstract :
No useful predictor of risk of acute heart failure in peripheral-blood stem-cell transplantation (PBSCT) regimens, including high-dose cyclophosphamide, has previously been available. Corrected QT dispersion can predict acute heart failure after high-dose cyclophosphamide chemotherapy used in PBSCT.
